Journal
CLINICAL INFECTIOUS DISEASES
Volume 32, Issue 4, Pages E81-E82Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/318705
Keywords
-
Categories
Ask authors/readers for more resources
Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available